NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
NuCana plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026
$0.98−0.01 (-1.30%)
Close on Oct 19, 2026
NuCana statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available
Valuation
| Market Cap | £3.07M |
|---|---|
| Enterprise Value | -£16.43M |
Income (trailing twelve months)
| Operating Income | -£20.11M |
|---|---|
| Pretax Income | -£30.52M |
| EBITDA | -£19.84M |
| EPS (Diluted) | 0.00 GBP |
Returns
| Return on Capital Employed (ROCE) | -96.0% |
|---|
Balance sheet
| Cash & Short-Term Investments | £19.50M |
|---|---|
| Net Cash (Debt) | £19.50M |
| Net Cash Per Share | 0.00 GBP |
| Working Capital | £18.00M |
Financial position
| Current Ratio | 4.73 |
|---|---|
| Quick Ratio | 4.21 |
| Interest Coverage | -1.59 |
Cash flow (trailing twelve months)
| Operating Cash Flow | -£7.47M |
|---|---|
| Capital Expenditures | £0 |
| Free Cash Flow | -£7.47M |
| FCF Per Share | -0.00 GBP |
Efficiency
| Employee Count | 12 |
|---|
Dividends and yields
| FCF Yield | -242.9% |
|---|---|
| Buyback Yield | -656.6% |
| Shareholder Yield | -656.6% |
Shares
| Shares Outstanding | 20,809,900,000 |
|---|---|
| Shares Change (YoY) | 15038.7% |
| Float | 17,971,400,000 |
| Shares Held by Insiders | 13.6% |
| Shares Held by Institutions | 0.00% |
Taxes
| Income Tax | -£1.17M |
|---|
Scores
| Altman Z-Score | -15.18 |
|---|
Calculated by StockData from NuCana's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.